Interpharm Holdings Announces Agreements With Tris Pharma

Interpharm Holdings has entered into two separate technology licensing and product development agreements with Tris Pharma, a specialty drug delivery technology company. These two agreements, collectively, will increase the company's pipeline of drugs under development over the next 30 months by up to 32 generic pharmaceutical products.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19242720&full=1)